1. Home
  2. ALMS vs GDEV Comparison

ALMS vs GDEV Comparison

Compare ALMS & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • GDEV
  • Stock Information
  • Founded
  • ALMS 2021
  • GDEV 2009
  • Country
  • ALMS United States
  • GDEV Cyprus
  • Employees
  • ALMS N/A
  • GDEV N/A
  • Industry
  • ALMS
  • GDEV EDP Services
  • Sector
  • ALMS
  • GDEV Technology
  • Exchange
  • ALMS NYSE
  • GDEV Nasdaq
  • Market Cap
  • ALMS 402.6M
  • GDEV 384.5M
  • IPO Year
  • ALMS 2024
  • GDEV N/A
  • Fundamental
  • Price
  • ALMS $4.13
  • GDEV $14.27
  • Analyst Decision
  • ALMS Strong Buy
  • GDEV Buy
  • Analyst Count
  • ALMS 6
  • GDEV 1
  • Target Price
  • ALMS $19.80
  • GDEV $70.00
  • AVG Volume (30 Days)
  • ALMS 686.1K
  • GDEV 9.2K
  • Earning Date
  • ALMS 08-12-2025
  • GDEV 09-03-2025
  • Dividend Yield
  • ALMS N/A
  • GDEV N/A
  • EPS Growth
  • ALMS N/A
  • GDEV N/A
  • EPS
  • ALMS N/A
  • GDEV 1.38
  • Revenue
  • ALMS $17,389,000.00
  • GDEV $420,933,000.00
  • Revenue This Year
  • ALMS N/A
  • GDEV N/A
  • Revenue Next Year
  • ALMS N/A
  • GDEV $11.69
  • P/E Ratio
  • ALMS N/A
  • GDEV $10.43
  • Revenue Growth
  • ALMS N/A
  • GDEV N/A
  • 52 Week Low
  • ALMS $2.76
  • GDEV $8.60
  • 52 Week High
  • ALMS $13.11
  • GDEV $42.76
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • GDEV 39.32
  • Support Level
  • ALMS N/A
  • GDEV $14.87
  • Resistance Level
  • ALMS N/A
  • GDEV $16.50
  • Average True Range (ATR)
  • ALMS 0.00
  • GDEV 1.71
  • MACD
  • ALMS 0.00
  • GDEV -0.08
  • Stochastic Oscillator
  • ALMS 0.00
  • GDEV 41.00

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About GDEV GDEV Inc.

GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.

Share on Social Networks: